(Alliance News) - The FTSE 100 opened higher on Thursday, with pharmaceutical firm GSK helping London's large-cap index outperform, though it was an uncertain start elsewhere in Europe despite Chinese shares surging. Read More
(Alliance News) - The FTSE 100 is called to open higher on Thursday, as eyes turn to US inflation data later, while a supportive move by the People's Bank of China lifted shares in Hong Kong and Shanghai. Read More
(Alliance News) - GSK PLC on Wednesday agreed to pay up to USD2.2 billion to settle the vast majority of cases linked to its heartburn medicine Zantac. Read More
(Alliance News) - GSK PLC on Tuesday said its Arexvy treatment was effective in treating patients suffering from a deadly respiratory virus with underlying medical conditions, paving the way for increased protection. Read More
(Alliance News) - Pfizer Inc sold a 7.6% stake in consumer health products firm Haleon PLC for GBP2.7 billion, the investment banks running the offer confirmed on Tuesday. Read More
(Alliance News) - Pfizer Inc on Monday said it plans to sell a 5.9% stake in consumer products firm, Haleon PLC, in a deal that could raise around GBP2.7 billion. Read More
(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. Read More
(Alliance News) - The FTSE 100 was called higher on Tuesday morning, ahead of US consumer confidence data and following news that Australia's central bank has resisted any temptation to cut rates. Read More
(Alliance News) - GSK PLC on Tuesday said its Blenrep cancer treatment will undergo review in Japan after successful authorisations recently in the UK and Europe. Read More
(Alliance News) - GSK PLC on Friday announced that it has been granted breakthrough therapy designation in China for Blenrep, a treatment for relapsed or refractory multiple myeloma. Read More
(Alliance News) - GSK PLC on Thursday hailed a "significant advancement" as it reported positive findings from a trial on a possible flu vaccine. Read More
(Alliance News) - Stocks prices in London are called to open sharply higher on Thursday, after a rip-roaring climb for US tech shares overnight helped settle the mood in equities before a eurozone interest rate decision. Read More
(Alliance News) - London's FTSE 100 underperformed European peers, but headed into Wednesday afternoon just about in the green as a US inflation reading looms. Read More
(Alliance News) - GSK PLC on Wednesday said that its vaccine candidate for the herpes simplex virus did not meet a primary efficacy objective in testing, and will not progress to the next phase of studies. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
